You are here: Industry Insights > Asthma

News List

Eczema drug effective against severe asthma worldpharmanews
June 05, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.
GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age drugs
May 31, 2018
GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma in children from as
Institute for Clinical and Economic Review to Assess Biologic Treatments for Asthma in Upcoming Assessment firstwordpharma
April 26, 2018
The Institute for Clinical and Economic Review (ICER) today announced plans to develop a review assessing the comparative clinical effectiveness and value of biologic therapies for moderate-to-severe asthma.
EMA to review Sanofi’s Dupixent drug for asthma pharmaceutical-technolog
April 09, 2018
The European Medicines Agency (EMA) has agreed to review an application submitted by Sanofi for the use of Dupixent (dupilumab) to treat inadequately controlled moderate-to-severe asthma.
Single steroid-bronchodilator treatment improves persistent asthma europeanpharmaceuticalreview
March 21, 2018
UConn-led review finds new class of long-acting bronchodilators effective for patients with uncontrolled asthma…
FDA to review Dupixent® (dupilumab) as potential treatment for moderate-to-severe asthma worldpharmanews
March 13, 2018
The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application of Dupixent® (dupilumab) as an add-on maintenance treatment in certain adults and adolescents (12 years of age and older) with moderate-to-s
EU expands scope of GSK/Innoviva’s asthma inhaler pharmatimes
March 12, 2018
The European Commission has approved a label update to GlaxoSmithKline/Innoviva’s Relvar Ellipta, expanding the asthma therapy’s reach.
Study of childhood asthma cautions against short-term high-dose treatment with steroids europeanpharmaceuticalreview
March 08, 2018
Researchers in the US have found that a common practice among physicians to increase the use of steroids for worsening symptoms of asthma in children may be associated with slowing a child’s rate of growth.
GSK’s Nucala improves control of severe asthma pharmatimes
March 07, 2018
GlaxoSmithKline has presented data showing that its biologic Nucala improved asthma control in patients with severe disease not adequately managed with Novartis’ Xolair.
Sanofi and Regeneron Seek FDA Approval of Dupixent as Add-On Asthma Therapy biospace
March 05, 2018
Asthma patients may soon have a new treatment option.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page